Cargando…
UMOD and you! Explaining a rare disease diagnosis
The precise molecular genetic diagnosis of a rare inherited disease is nearly always a prolonged odyssey. Fortunately, modern molecular testing strategies are allowing more diagnoses to be made. There are many different rare inherited kidney diseases and both the genetic heterogeneity of these condi...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767401/ https://www.ncbi.nlm.nih.gov/pubmed/36569465 http://dx.doi.org/10.1007/s44162-022-00005-4 |
_version_ | 1784853959375060992 |
---|---|
author | Mabillard, Holly Olinger, Eric Sayer, John A. |
author_facet | Mabillard, Holly Olinger, Eric Sayer, John A. |
author_sort | Mabillard, Holly |
collection | PubMed |
description | The precise molecular genetic diagnosis of a rare inherited disease is nearly always a prolonged odyssey. Fortunately, modern molecular testing strategies are allowing more diagnoses to be made. There are many different rare inherited kidney diseases and both the genetic heterogeneity of these conditions and the clinical diversity often leads to confusing nomenclature. Autosomal dominant tubulointerstitial kidney disease (ADTKD) is an example of this. ADTKD, an inherited kidney disease that leads to worsening of kidney function over time, often culminating in end stage kidney disease, accounting for around 2% of this cohort. UMOD is the most common gene implicated in this disorder but there are at least 6 subtypes. At present, there are no specific treatments for ADTKD. Here, we review the current understanding of this condition and provide patient-centred information to allow conceptual understanding of this disease to allow better recognition, diagnosis and management. |
format | Online Article Text |
id | pubmed-9767401 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-97674012022-12-21 UMOD and you! Explaining a rare disease diagnosis Mabillard, Holly Olinger, Eric Sayer, John A. J Rare Dis (Berlin) Review The precise molecular genetic diagnosis of a rare inherited disease is nearly always a prolonged odyssey. Fortunately, modern molecular testing strategies are allowing more diagnoses to be made. There are many different rare inherited kidney diseases and both the genetic heterogeneity of these conditions and the clinical diversity often leads to confusing nomenclature. Autosomal dominant tubulointerstitial kidney disease (ADTKD) is an example of this. ADTKD, an inherited kidney disease that leads to worsening of kidney function over time, often culminating in end stage kidney disease, accounting for around 2% of this cohort. UMOD is the most common gene implicated in this disorder but there are at least 6 subtypes. At present, there are no specific treatments for ADTKD. Here, we review the current understanding of this condition and provide patient-centred information to allow conceptual understanding of this disease to allow better recognition, diagnosis and management. Springer Berlin Heidelberg 2022-12-07 2022 /pmc/articles/PMC9767401/ /pubmed/36569465 http://dx.doi.org/10.1007/s44162-022-00005-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review Mabillard, Holly Olinger, Eric Sayer, John A. UMOD and you! Explaining a rare disease diagnosis |
title | UMOD and you! Explaining a rare disease diagnosis |
title_full | UMOD and you! Explaining a rare disease diagnosis |
title_fullStr | UMOD and you! Explaining a rare disease diagnosis |
title_full_unstemmed | UMOD and you! Explaining a rare disease diagnosis |
title_short | UMOD and you! Explaining a rare disease diagnosis |
title_sort | umod and you! explaining a rare disease diagnosis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767401/ https://www.ncbi.nlm.nih.gov/pubmed/36569465 http://dx.doi.org/10.1007/s44162-022-00005-4 |
work_keys_str_mv | AT mabillardholly umodandyouexplainingararediseasediagnosis AT olingereric umodandyouexplainingararediseasediagnosis AT sayerjohna umodandyouexplainingararediseasediagnosis |